EUVIMEDEUVIMED entdecken
LeitlinieSystematische ÜbersichtOpen Access

Vaccination of Adults With Cancer: ASCO Guideline

Mini Kamboj, Kari Bohlke iD, Deana M Baptiste, Kieron Dunleavy, Abbey Fueger, Lee Jones iD, Amar H Kelkar iD, Lisa Y Law iD, Kristine B LeFebvre iD, Per Ljungman iD, Eric D Miller iD, Larissa A Meyer iD und 5 weitere

Journal of Clinical Oncology · 10.05.2024 · 42 (14) · 1699-1721

DOI: 10.1200/jco.24.00032 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.05.2024. Verfasst von Mini Kamboj und 16 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY. Hauptthemen laut MEDLINE: Neoplasms, Vaccination, COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 138-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual . ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines . Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by providers and should be used in conjunction with independent professional judgment. Guidance may not be applicable to all patients, interventions, diseases or stages of diseases. Guidance is based on review and analysis of relevant literature, and is not intended as a statement of the standard of care. ASCO does not endorse third-party drugs, devices, services, or therapies and assumes no responsibility for any harm arising from or related to the use of this information. See complete disclaimer in Appendix 1 and Appendix 2 (online only) for more. PURPOSE To guide the vaccination of adults with solid tumors or hematologic malignancies. METHODS A systematic literature review identified systematic reviews, randomized controlled trials (RCTs), and nonrandomized studies on the efficacy and safety of vaccines used by adults with cancer or their household contacts. This review builds on a 2013 guideline by the Infectious Disease Society of America. PubMed and the Cochrane Library were searched from January 1, 2013, to February 16, 2023. ASCO convened an Expert Panel to review the evidence and formulate recommendations. RESULTS A total of 102 publications were included in the systematic review: 24 systematic reviews, 14 RCTs, and 64 nonrandomized studies. The largest body of evidence addressed COVID-19 vaccines. RECOMMENDATIONS The goal of vaccination is to limit the severity of infection and prevent infection where feasible. Optimizing vaccination status should be considered a key element in the care of patients with cancer. This approach includes the documentation of vaccination status at the time of the first patient visit; timely provision of recommended vaccines; and appropriate revaccination after hematopoietic stem-cell transplantation, chimeric antigen receptor T-cell therapy, or B-cell–depleting therapy. Active interaction and coordination among healthcare providers, including primary care practitioners, pharmacists, and nursing team members, are needed. Vaccination of household contacts will enhance protection for patients with cancer. Some vaccination and revaccination plans for patients with cancer may be affected by the underlying immune status and the anticancer therapy received. As a result, vaccine strategies may differ from the vaccine recommendations for the general healthy adult population vaccine. Additional information is available at www.asco.org/supportive-care-guidelines .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsVaccinationCOVID-19 VaccinesCOVID-19HumansAdultSARS-CoV-2

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
  • American Society of Clinical Oncology, Alexandria, VA.
  • American Cancer Society, Atlanta, GA.
  • MedStar Georgetown University Hospital, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.
  • The Leukemia and Lymphoma Society, Rye Brook, NY.
  • Fight Colorectal Cancer, Arlington, VA.

ORCID-Profile: Kari Bohlke, Lee Jones, Amar H Kelkar, Lisa Y Law, Kristine B LeFebvre, Per Ljungman, Eric D Miller, Larissa A Meyer, Heather N Moore, Heloisa P Soares, Randy A Taplitz, Edom S Woldetsadik

Zitieren

APA

Kamboj, M., Bohlke, K., Baptiste, D. M., Dunleavy, K., Fueger, A., Jones, L., Kelkar, A. H., Law, L. Y., LeFebvre, K. B., Ljungman, P., Miller, E. D., Meyer, L. A., Moore, H. N., Soares, H. P., Taplitz, R. A., Woldetsadik, E. S., & Kohn, E. C. (2024). Vaccination of Adults With Cancer: ASCO Guideline. Journal of Clinical Oncology, 42(14), 1699-1721. https://doi.org/10.1200/jco.24.00032

Vancouver

Kamboj M, Bohlke K, Baptiste DM, Dunleavy K, Fueger A, Jones L, et al. Vaccination of Adults With Cancer: ASCO Guideline. Journal of Clinical Oncology. 2024;42(14):1699-1721. doi:10.1200/jco.24.00032

BibTeX
@article{Kamboj2024,
  author = {Kamboj, Mini and Bohlke, Kari and Baptiste, Deana M and Dunleavy, Kieron and Fueger, Abbey and Jones, Lee and Kelkar, Amar H and Law, Lisa Y and LeFebvre, Kristine B and Ljungman, Per and Miller, Eric D and Meyer, Larissa A and Moore, Heather N and Soares, Heloisa P and Taplitz, Randy A and Woldetsadik, Edom S and Kohn, Elise C},
  title = {Vaccination of Adults With Cancer: ASCO Guideline},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  volume = {42},
  number = {14},
  pages = {1699--1721},
  doi = {10.1200/jco.24.00032}
}
Kostenlos starten →